| |
| Device | DEXCOM G4TM PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM; DEXCON G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM |
| Generic Name | Sensor, glucose, invasive |
| Applicant | Dexcom, Inc. 6340 Sequence Dr. San Diego, CA 92121 |
| PMA Number | P120005 |
| Supplement Number | S039 |
| Date Received | 09/23/2015 |
| Decision Date | 10/23/2015 |
| Withdrawal Date | 03/20/2026 |
| Product Code |
MDS |
| Advisory Committee |
Clinical Chemistry |
| Clinical Trials | NCT01514292
|
| Supplement Type | 30-Day Notice |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement REMOVAL OF AN IN-PROCESS INSPECTION TESTING PERFORMED DURING THE MANUFACTURING PROCESS OF THE G4 PLATINUM AND G5 MOBILE TRANSMITTERS. THE G4 PLATINUM AND THE G5 MOBILE TRANSMITTERS ARE COMPONENTS OF THE G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM AND G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM, RESPECTIVELY. |